Literature DB >> 20789442

Inactivated Measles Virus Vaccine.

.   

Abstract

Entities:  

Year:  1962        PMID： 20789442      PMCID： PMC1959073     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Concentrated inactivated measlesvirus vaccine. Preparation and antigenic potency.

Authors:  J WARREN; M J GALLIAN
Journal:  Am J Dis Child       Date:  1962-03

2.  Inactivated measles virus vaccine. III. A field trial in young school children.

Authors:  W WINKELSTEIN; R JENSS; G E GRESHAM; D T KARZON; W E MOSHER
Journal:  JAMA       Date:  1962-02-10       Impact factor: 56.272

3.  Action of anticellular sera on virus infections. II. Influence on heterologous tissue cultures.

Authors:  L QUERSIN-THIRY
Journal:  J Immunol       Date:  1959-06       Impact factor: 5.422

4.  Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.

Authors:  J F ENDERS; S L KATZ; M V MILOVANOVIC; A HOLLOWAY
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

5.  Experience with measles immunization. Alum-absorbed killed measles-virus vaccine and live measles-virus vaccine challenge.

Authors:  S KARELITZ; F B PECK
Journal:  Am J Dis Child       Date:  1962-03

6.  Propagation in tissue cultures of cytopathogenic agents from patients with measles.

Authors:  J F ENDERS; T C PEEBLES
Journal:  Proc Soc Exp Biol Med       Date:  1954-06

7.  Inactivated measles virus vaccine. II. Prevention of natural and experimental measles with the vaccine.

Authors:  H A FELDMAN; A NOVACK; J WARREN
Journal:  JAMA       Date:  1962-02-10       Impact factor: 56.272
  7 in total
  1 in total

1.  Measles vaccination before the measles-mumps-rubella vaccine.

Authors:  Jan Hendriks; Stuart Blume
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.